Abstract
In this educational post, I guide you through current best practices and emerging consensus in orthobiologics—particularly platelet-rich plasma (PRP) and adipose-derived therapies—while clarifying common nomenclature pitfalls and their clinical implications. I explain why the cellular composition of PRP matters, how neutrophil-rich formulations can provoke joint flares, and how mononuclear cell–dominant formulations may be better suited for intra-articular use. I also present pragmatic workflows for point-of-care preparation, discuss subchondral bone interventions, and elaborate on an integrative pathway that includes functional medicine, rehabilitation, weight management, and the optimization of chiropractic joint biomechanics. Importantly, I introduce our multidisciplinary model at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), with over 40 years of experience as an internist, serves as Medical Director and Collaborative Physician alongside me. Together, we coordinate comprehensive care that blends integrative chiropractic practice, medical oversight, orthobiologics, personal injury treatment, and rehabilitation to deliver patient-centered, data-driven outcomes.
Integrative Orthobiologics: Setting the Stage for Clarity and Clinical Precision
As a clinician working at the intersection of orthobiologics, functional medicine, and integrative chiropractic care, I have seen how confusion in terminology can lead to inconsistent patient outcomes. The most important starting point is understanding what is in any biologic you plan to inject. That requires knowing your processing system, interpreting cell counts, and asking targeted questions.
Key takeaway: Be deliberate about the cellular composition of biologics, especially PRP. Ask your vendor for validated white blood cell differentials, platelet counts, and independent, peer-reviewed performance data rather than relying solely on corporate white papers.
Clinical implication: Injecting neutrophil-rich PRP into a joint may produce post-injection pain flares and synovial irritation. Conversely, leukocyte-poor or mononuclear cell–dominant PRP appears better tolerated intra-articularly.
European approaches frequently use more manual phlebotomy and simple centrifugation, while many U.S. systems rely on proprietary kits that promise “leukocyte control.” In practice, I have observed that some kits reduce granulocytes (neutrophils) but raise lymphocytes, leading to confusing categorizations as “leukocyte-poor” despite white blood cell counts that may be the same or higher than baseline. This discrepancy underscores why accurate differential data—not just total WBC—must guide our choices.
Why this matters physiologically: Neutrophils are frontline innate immune responders that release reactive oxygen species, proteases, and pro-inflammatory cytokines when activated in synovial tissues. In osteoarthritic joints with a primed inflammatory milieu, neutrophil-rich PRP can amplify nociception, effusion, and stiffness. Monocytes/lymphocytes modulate inflammation differently, and certain mononuclear fractions may better support reparative signaling without exacerbating synovitis.
Citations:
Platelet-rich plasma for knee osteoarthritis: a systematic review and meta-analysis (JAMA Network Open, 2021) highlights differential outcomes by PRP characteristics and preparation methods.
Leukocyte content of PRP and clinical outcomes (Arthroscopy, 2016) discusses inflammation profiles associated with leukocyte-rich versus leukocyte-poor PRP.
PRP Composition: How to Select and Why It Matters
When I evaluate PRP options for intra-articular use, I prioritize formulations that concentrate platelets while minimizing neutrophils. The goal is to create a signaling environment that enhances growth factor delivery—including PDGF, TGF-β, VEGF, and IGF-1—without excessive acute inflammation.
Preferred intra-articular PRP: Leukocyte-poor, mononuclear cell–leaning, moderate to high platelet concentration (often targeted at 3–5x baseline).
Avoid: Neutrophil-rich PRP inside joints, given the higher likelihood of pain flares.
Physiological rationale:
Platelets release alpha granules rich in growth factors that stimulate synoviocytes, chondrocytes, and mesenchymal progenitors, enhancing matrix synthesis and anti-inflammatory signaling.
Neutrophils can drive catabolic activity via elastase and matrix metalloproteinases, potentially worsening cartilage wear in a susceptible joint.
How to validate composition:
Verify pre- and post-spin counts in your clinic when possible. Many centers, including ours, measure CBC with differential for the input and output to know exactly what we are injecting.
Adjust technique: Spin speed, time, kit selection, and plasma fraction collection change leukocyte and platelet distribution. Tuning these parameters yields biologically advantageous profiles.
Citations:
Growth factor content and PRP efficacy (Osteoarthritis and Cartilage, 2020).
PRP leukocyte content influences inflammation (Arthroscopy, 2016).
Adipose-Derived Options and Microneedle Patch Approaches: Where They Fit
For certain patients—particularly those with osteoarthritis, persistent joint effusions, or those who have exhausted other orthobiologic options—adipose-derived interventions can be considered as a second-line strategy. In select cases, a microneedle patch delivery approach can offer localized biologic signaling while minimizing invasiveness.
Patient selection: Individuals who are not candidates for joint replacement, who have recurrent effusions, or who seek a biologic adjunct after surgery.
Procedure flow (clinic-based): We typically perform this in a special procedure room, with the patient awake and comfortable. There is compelling safety data from plastic surgery that awake liposuction is safer than under general anesthesia.
Practical steps:
Use tumescent anesthesia and allow adequate dwell time. The longer the local anesthetic and saline remain in subcutaneous fat, the easier and safer the harvest. I aim for at least 20–30 minutes of dwell time to reduce pain and facilitate gentle collection.
Music, positioning, and patient comfort matter. We commonly have patients lie prone or lateral, use calming measures, and maintain continuous communication.
Physiological rationale:
Adipose tissue contains a stromal vascular fraction (SVF) that includes mesenchymal stromal cells, endothelial progenitors, and pericytes. These cells can secrete paracrine mediators that modulate synovial inflammation and support matrix turnover. Delivery via microneedle arrays may enhance tissue penetration and microenvironmental conditioning while reducing mechanical trauma compared with large-bore injections.
Citations:
Safety and outcomes of awake liposuction (Plastic and Reconstructive Surgery, 2018).
Adipose-derived cell therapies in OA (Osteoarthritis and Cartilage, 2022).
Subchondral Bone Decompression and Biologics: An Honest Appraisal
Subchondral bone interventions—whether needling/decompression, calcium phosphate augmentation, or bone marrow cell injections—show promise in carefully selected patients with osteochondral insufficiency or bone marrow lesions. Yet, across the literature, there tends to be a consistent failure rate around 20 percent.
What might be working: Pressure reduction from subchondral decompression, altered interstitial fluid dynamics, and reduced nociceptive signaling may account for part of the benefit, regardless of the injected agent.
Enhancers: Adding bone marrow–derived cells or bioceramics may improve microenvironmental stability, but decompression itself likely contributes substantially.
Orthobiologics do not exist in a vacuum; mechanical load is paramount. Treating the foundation—hip-knee-ankle alignment, quadriceps strength, gait mechanics, and weight-bearing strategies—often determines whether subchondral gains persist.
Integrative strategies:
Offloading braces or valgus/varus unloading devices
Weight loss where indicated to reduce joint compressive forces
Focused quadriceps and hip abductor strengthening
Smart chiropractic joint biomechanics assessments and corrections
Citations:
Subchondral bone marrow lesions and outcomes (Arthritis Care & Research, 2019).
Calcium phosphate and subchondral reinforcement (Journal of Bone and Joint Surgery, 2018).
Practical PRP Preparation: From Spin Parameters to Clinical Outcomes
When preparing PRP for a knee joint, many clinicians draw 60–120 mL of whole blood; some protocols extend to 180 mL to achieve target platelet yields while minimizing leukocyte contamination. The specific volumes depend on the kit's efficiency, the patient's baseline counts, and the desired platelet concentration.
Steps to optimize:
Verify pre-spin CBC and post-spin PRP counts.
Adjust centrifugation speeds and spin durations to limit granulocyte contamination.
Select collection fractions (above buffy coat for leukocyte-poor) carefully.
Maintain aseptic technique and minimize shear stress to platelets.
Why technique matters:
Excessive shear or repeated high-speed spins can disrupt platelet membranes, prematurely releasing factors and reducing functional bioactivity upon injection. Controlled processing preserves platelet integrity and timely growth factor release.
Citations:
Effect of centrifugation on PRP composition (American Journal of Sports Medicine, 2016).
PRP preparation techniques and clinical efficacy (Arthritis Research & Therapy, 2020).
Integrative Chiropractic Care: Biomechanics, Load, and Synovial Health
In our clinic, integrative chiropractic care is central to the success of orthobiologic therapies. My approach focuses on biomechanical optimization, regional interdependence, and load management.
Chiropractic roles:
Assess and correct pelvic tilt, leg length discrepancy, and lumbar-pelvic alignment that can shift knee loads.
Mobilize restricted joints to restore normal arthrokinematics, particularly in the ankle and hip, which influence knee kinematics through kinetic chains.
Apply soft tissue techniques to reduce myofascial adhesions in the quadriceps, IT band, and posterior chain that contribute to maltracking and patellofemoral overload.
Physiological mechanisms:
Improved joint congruence reduces aberrant shear on articular cartilage, mitigating synovial irritation and decreasing neurogenic inflammation. By modulating proprioceptive input and muscle firing patterns, chiropractic interventions can enhance joint stability, supporting the reparative milieu induced by PRP or adipose-derived signals.
Clinical observations:
In my practice, when patients adhere to biomechanical corrections and a progressive strength program, we observe more durable pain reduction following orthobiologics. These insights are reflected across my published clinical narratives and case discussions:
dralexjimenez.com
elpasochiropractorblog.com
linkedin.com/in/dralexjimenez
Citations:
Knee osteoarthritis biomechanics and load management (British Journal of Sports Medicine, 2021).
Manual therapy effects on pain and function (Musculoskeletal Science and Practice, 2018).
Functional Medicine Integration: Inflammation, Metabolism, and Joint Recovery
A functional medicine framework enhances joint recovery by addressing systemic drivers of low-grade inflammation, metabolic dysregulation, and microvascular health. As a CFMP and IFMCP clinician, I incorporate:
Nutritional interventions:
Mediterranean-style or low-glycemic diets to reduce insulin resistance and adipokine-mediated inflammation.
Omega-3 fatty acids, curcumin, and vitamin D to modulate inflammatory pathways while ensuring evidence-based dosing and safety.
Metabolic assessment:
Evaluate HbA1c, fasting glucose/insulin, CRP, lipid profiles, and liver function to tailor interventions.
Microbiome considerations:
Gut barrier integrity influences systemic inflammation via LPS translocation; select strategies that support short-chain fatty acid production and mucosal immunity can indirectly reduce joint symptom burden.
Physiological rationale:
Lowering systemic NF-κB activation and improving endothelial function support synovial perfusion and cartilage homeostasis, potentiating the benefits of PRP and other orthobiologics.
Citations:
Dietary patterns and OA inflammation (Osteoarthritis and Cartilage, 2019).
Omega-3 and pain modulation (BMJ Open, 2018).
Personal Injury Care and Rehabilitation: Coordinated Recovery Under Medical Oversight
At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), we treat many personal injury cases. These patients benefit from tight coordination between medical oversight and manual therapy:
Oversight by Dr. Maria Guadalupe Cardenas, MD:
As Medical Director and Collaborative Physician, Dr. Cardenas leads medical risk assessment, medication management, and diagnostic pathways. With over 40 years of experience in Internal Medicine, she ensures safety and clinical appropriateness for each biologic intervention, especially in complex comorbid profiles.
Rehabilitation:
Progressive strengthening, neuromuscular re-education, and kinetic chain conditioning to distribute loads evenly across joints.
Use of blood flow restriction training where indicated to enhance muscular adaptation with reduced joint stress.
Workflow synergy:
Medical screening identifies contraindications (e.g., coagulopathies, active infections, poorly controlled diabetes).
Chiropractic assessments determine mechanical contributors to pain and guide joint-specific corrections.
Functional medicine normalizes metabolic and inflammatory inputs.
Orthobiologics are then deployed in a low-inflammation, well-aligned environment to maximize yield.
Citations:
Integrated care models for musculoskeletal injury (Journal of General Internal Medicine, 2019).
Blood flow restriction rehabilitation (Journal of Orthopaedic & Sports Physical Therapy, 2019).
Safety, Protocols, and Informed Consent: Why Details Prevent Unhappy Outcomes
The difference between a good outcome and a poor one often lies in protocol fidelity:
For PRP:
Confirm platelet counts and leukocyte differentials at point-of-care when possible.
Document kit type, spin parameters, and fraction selection.
For adipose-derived harvest:
Ensure adequate tumescent dwell time (minimum 20 minutes, preferably 30 minutes) to reduce pain and improve tissue yield.
Maintain sterility and preserve cell viability with gentle handling.
Informed consent details:
Clarify that orthobiologics are not universally effective; set expectations of response heterogeneity and potential need for multimodal care, including mechanical offloading and strengthening.
Citations:
Standardization in orthobiologics (American Journal of Sports Medicine, 2020).
Adipose cell viability and handling (Tissue Engineering Part A, 2018).
When a Needle Alone Helps: Decompression, Pressure, and the Microenvironment
An interesting phenomenon appears throughout the subchondral literature: decompression itself may reduce pain independent of the substance injected. Lowering interstitial pressure can improve microcirculation, reduce marrow edema, and diminish periosteal nociceptor activation.
Translational insight:
We support decompression with load modification: braces, gait retraining, weight loss, and precise chiropractic corrections. Doing more than one thing—decompression plus environmental change—increases the odds of success beyond a single-needle intervention.
Citations:
Bone marrow edema pathophysiology (Osteoarthritis and Cartilage, 2013).
Load-altering braces and OA outcomes (Arthritis Care & Research, 2018).
Our Multidisciplinary Model in El Paso: How We Work Together
I am proud to share that Dr. Maria Guadalupe Cardenas, MD, serves as the Medical Director and Collaborative Physician at our practice, Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), in El Paso, Texas. Dr. Cardenas is Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933, with over 40 years of experience as an internist.
Team roles:
Dr. Cardenas: Medical governance, risk mitigation, comprehensive internal medicine oversight, lab interpretation, co-development of evidence-based protocols.
Dr. Jimenez: Integrative chiropractic care, orthobiologics selection and delivery, functional medicine, musculoskeletal diagnostics, and biomechanical optimization.
Rehabilitation staff: Guided exercise therapy, progressive load tolerance, movement pattern correction.
Integrated pathway:
Medical assessment: Comorbidity screening, labs, imaging, contraindications.
Chiropractic biomechanical evaluation: Alignment, joint motion, soft tissue status.
Functional medicine workup: Nutrition, inflammation markers, metabolic risks.
Orthobiologic selection: PRP composition tuned to joint biology; adipose-derived options as second-line for persistent cases.
Rehabilitation and load strategy: Strengthening, bracing, gait training.
Outcome tracking: Pain scores, range of motion, function, repeat CBC/PRP profile verification.
This multidisciplinary model, common to integrative and injury care clinics, ensures that patients receive coordinated care blending medical rigor with hands-on biomechanical expertise.
Citations:
Multidisciplinary musculoskeletal clinics improve outcomes (BMC Health Services Research, 2020).
Patient Selection and Practical Notes: Microneedle Patch and Awake Adipose Harvest
In clinic-based adipose harvests:
Patient selection: Osteoarthritis patients without better options, those with effusions, post-surgical adjuncts, or individuals who have not responded to prior orthobiologics.
Comfort optimization: a calm environment, music, and clear communication. Although not “visible” in the sense of large surgical instrumentation, patients can feel mild sensations; we aim to keep discomfort to a minimum and manageable.
Rationale for awake procedures:
Awake procedures reduce anesthesia-related risks. The Tumescent technique provides local anesthesia and vasoconstriction, improving safety and ease of harvest.
Citations:
Tumescent techniques and safety (Plastic and Reconstructive Surgery, 2020).
Nomenclature Matters: Avoiding Misinterpretation in PRP Labeling
One of the main pitfalls for clinicians new to orthobiologics is nomenclature inconsistency. Systems branded as “leukocyte-poor” may still have elevated lymphocyte and total WBC counts that are equal to or higher than baseline, despite reduced neutrophils. If you mistakenly equate “leukocyte-poor” with uniformly low WBCs, you may choose formulations inappropriate for joints.
Action points:
Request cellular differentials from manufacturers and cross-check against peer-reviewed studies using the same system.
Implement clinic-level pre/post analysis to confirm actual composition delivered.
Consequences:
Injecting a neutrophil-high preparation intra-articularly can yield unhappy patients due to flares. Vet the product with diligence before clinical deployment.
Citations:
Standardized reporting recommendations for PRP (Arthroscopy, 2020).
The Limits and Opportunities: Doing More Than One Thing Well
No single biologic is universally effective. The data suggest:
Approximately 80 percent respond favorably to certain subchondral interventions, while ~20 percent do not and may require alternate strategies.
Outcomes improve when we pair biologics with mechanical offloading, strengthening, and metabolic optimization.
Clinical philosophy:
There is limited “magic” in a syringe. The real gains come from comprehensive care: correct loads, optimize biology, and ensure proper technique.
Citations:
Comprehensive OA management improves function (Arthritis Care & Research, 2021).
Summary Points: What I Want You to Remember
Be precise with PRP composition: favor a mononuclear-dominant, neutrophil-poor intra-articular composition.
Validate with pre- and post-counts; don’t rely solely on kit labels.
Consider adipose-derived approaches as second-line for persistent effusions or complex OA.
Allow adequate tumescent dwell time (20–30 minutes) for comfortable, effective harvest.
Treat the mechanical foundation: use integrative chiropractic care, strength training, bracing, and weight management.
Recognize the role of medical oversight: Dr. Maria Guadalupe Cardenas, MD, directs safety, diagnostics, and systems-level coordination at our clinic in El Paso.
Track outcomes and iterate: orthobiologics work best within a multidisciplinary, evidence-based framework.
References
Platelet-rich plasma for knee osteoarthritis: a systematic review and meta-analysis. (2021). JAMA Network Open.
Leukocyte content of PRP and clinical outcomes. (2016). Arthroscopy.
Growth factor content and PRP efficacy. (2020). Osteoarthritis and Cartilage.
PRP leukocyte content influences inflammation. (2016). Arthroscopy.
Safety and outcomes of awake liposuction. (2018). Plastic and Reconstructive Surgery.
Adipose-derived cell therapies in OA. (2022). Osteoarthritis and Cartilage.
Subchondral bone marrow lesions and outcomes. (2019). Arthritis Care & Research.
Calcium phosphate and subchondral reinforcement. (2018). Journal of Bone and Joint Surgery.
Effect of centrifugation on PRP composition. (2016). American Journal of Sports Medicine.
PRP preparation techniques and clinical efficacy. (2020). Arthritis Research & Therapy.
Knee osteoarthritis biomechanics and load management. (2021). British Journal of Sports Medicine.
Manual therapy effects on pain and function. (2018). Musculoskeletal Science and Practice.
Dietary patterns and OA inflammation. (2019). Osteoarthritis and Cartilage.
Omega-3 and pain modulation. (2018). BMJ Open.
Integrated care models for musculoskeletal injury. (2019). Journal of General Internal Medicine.
Standardization in orthobiologics. (2020). American Journal of Sports Medicine.
Adipose cell viability and handling. (2018). Tissue Engineering Part A.
Bone marrow edema pathophysiology. (2013). Osteoarthritis and Cartilage.
Load-altering braces and OA outcomes. (2018). Arthritis Care & Research.
Multidisciplinary musculoskeletal clinics improve outcomes. (2020). BMC Health Services Research.
Comprehensive OA management improves function. (2021). Arthritis Care & Research.
Tumescent techniques and safety. (2020). Plastic and Reconstructive Surgery.
Standardized reporting recommendations for PRP. (2020). Arthroscopy.
The information herein is not intended to replace a one-on-one relationship with a qualified healthcare professional or licensed physician and is not medical advice. We encourage you to make healthcare decisions based on your research and partnership with a qualified healthcare professional. Our information scope is limited to chiropractic, musculoskeletal, and physical medicine, as well as wellness, sensitive health issues, and functional medicine articles, topics, and discussions. We provide and facilitate clinical collaboration with specialists across disciplines. Each specialist is governed by their professional scope of practice and the jurisdiction in which they are licensed. We utilize functional health and wellness protocols to treat and support care for musculoskeletal injuries or disorders. Our videos, posts, topics, subjects, and insights cover clinical matters and issues that directly or indirectly support our clinical scope of practice. Our office has made a reasonable effort to provide supportive citations and identify relevant research studies for our posts. We provide copies of supporting research studies upon request to regulatory boards and the public.
We are here to help you and your family.
Blessings
Dr. Alex Jimenez, DC, MSACP, APRN, FNP-BC*, CCST, IFMCP, CFMP, ATN
email: coach@elpasofunctionalmedicine.com
Multidisciplinary Licensing & Board Certifications:
Licensed as a Doctor of Chiropractic (DC) in Texas & New Mexico*
Texas DC License #: TX5807, Verified: TX5807
New Mexico DC License #: NM-DC2182, Verified: NM-DC2182
Multi-State Advanced Practice Registered Nurse (APRN*) in Texas & Multi-States
Multi-State Compact APRN License by Endorsement (42 States)
Texas APRN License #: 1191402, Verified: 1191402 *
Florida APRN License #: 11043890, Verified: APRN11043890 *
New York APRN License #: N25929, Verified: APRN-N25929*
License Verification Link: Nursys License Verifier
* Prescriptive Authority Authorized
ANCC FNP-BC: Board Certified Nurse Practitioner*
Compact Status: Multi-State License: Authorized to Practice in 40 States*
Graduate with Honors: ICHS: MSN-FNP (Family Nurse Practitioner Program)
Degree Granted. Master's in Family Practice MSN Diploma (Cum Laude)
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
My Digital Business Card
Dr. Maria Cardenas, MD
(Board Certified in Internal Medicine)
Medical Director & Collaborative Physician
NPI # 1164426749
MD License #: J2933
